Correlation between Treatment Outcomes and Serum Vitamin D Levels As Well As Infliximab Trough Concentration among Chinese Patients with Crohn’s Disease
Table 1
Demographic characteristics.
Variables
Number of patients
84
Age (y)
26 (22–34)
Gender
Female (%)
24 (28.60)
Male (%)
60 (71.43)
Height (m) ()
Weight (kg) ()
BMI
Underweight (%)
44 (52.38)
Normal weight (%)
39 (46.43)
Preobese (%)
1 (1.19)
Obese (%)
0
Provinces
Chongqing (%)
73 (86.90)
Sichuan (%)
9 (10.71)
Others (%)
2 (2.38)
Employment situation
Unemployed (%)
38 (45.24)
Employed (%)
46 (54.76)
Occupation
Indoor (%)
79 (94.05)
Outdoor (%)
5(5.95)
Marital status
Unmarried (%)
49 (58.33)
Married (%)
33 (39.29)
Divorced (%)
3 (3.57)
Smoking status
No (%)
64 (76.19)
Yes (%)
20 (23.81)
Education background
Primary school, (%)
1 (1.19)
Middle school (%)
9 (10.71)
Senior high school (%)75
24 (28.57)
University and above (%)
50 (59.52)
Course of disease mean (IQR)/
2.99 (1.64–5.56)/84
Clinical symptoms
Abdominal
51 (60.71)
Diarrhea
35 (41.67)
Hematochezia
6 (7.14)
Crissum diseases
4 (4.76)
Extraintestinal manifestations
6 (7.14)
Fever
2 (2.38)
Intestinal surgery, (%)
No
21 (25.00)
Yes
63 (75.00)
Perianal surgery, (%)
No
37 (44.05)
Yes
47 (55.95)
IMM
No
53 (63.10)
Yes
31 (36.90)
IMM type
Azathioprine
27 (90.00)
Methotrexate
2 (6.67)
Thalidomide
1 (3.33)
Diagnosis age, (%)
y
4 (4.76)
A2 17~40 y
68 (80.95)
y
12 (14.29)
Disease extent, (%)
L1
20 (23.81)
L2
10 (11.90)
L3
47 (55.95)
6 (7.14)
1 (1.19)
Behavior, (%)
B1
45 (53.57)
B2
26 (30.95)
B3
13 (15.48)
Perianal lesions
No
29 (34.52)
Yes
55 (65.48)
y, year; m, month; SD, standard deviation; kg, kilogram; BMI, body mass index; IQR, interquartile range; IMM, immunosuppressant.
